Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine
Open Access
- 1 January 2017
- journal article
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 13 (1), 26-29
- https://doi.org/10.17925/EE.2017.13.01.26
Abstract
Background: The Thyroid Cancer Care Collaborative developed a web-based clinical decision-making module (CDMM) to inform riskadjusted decisions on post-thyroidectomy radioactive iodine (RAI) use in papillary thyroid cancer (PTC). Methods: In a pilot study, we evaluated the CDMM in 19 PTC cases representing low- (five), intermediate- (seven) and high-risk (seven) disease. Two PTC experts and 10 PTC physicians reviewed cases and assigned risk level and RAI recommendation. The experts used a standard approach while the others used the CDMM. We assessed agreement between responses using a weighted Kappa. Results: Between experts, risk-assignment was concordant in 100%, 57% and 86% of low-, intermediate- and high-risk cases, respectively. Between CDMM users, risk-assignment was concordant in 100%, 29% and 14% in low-, intermediate- and high-risk cases, respectively (p=0.01). CDMM-assigned risk agreed with the expert-assigned risk in 100%, 25% and 0% of low-, intermediate- and high-risk cases, respectively (Kappa=0.69). For RAI use, the experts agreed in 15 cases while CDMM users agreed in eight. On further analysis, interpretation of extrathyroidal extension and lymph node staging led to discrepancies with the CDMM. ConclusionsKeywords
This publication has 15 references indexed in Scilit:
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Incidental Thyroid Nodules and Thyroid CancerJAMA Otolaryngology–Head & Neck Surgery, 2015
- Cancer statistics, 2015CA: A Cancer Journal for Clinicians, 2015
- The 2009 American Thyroid Association Guidelines Modestly Reduced Radioactive Iodine Use for Thyroid Cancers Less Than 1 cmThyroid®, 2014
- Current Thyroid Cancer Trends in the United StatesJAMA Otolaryngology–Head & Neck Surgery, 2014
- Cancers with increasing incidence trends in the United States: 1999 through 2008CA: A Cancer Journal for Clinicians, 2012
- Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapyCancer, 2011
- Localized well-differentiated thyroid carcinoma: survival analysis of prognostic factors and (131)I therapy.Annals of Surgical Oncology, 1998
- Impact of Therapy for Differentiated Carcinoma of the Thyroid: An Analysis of 706 Cases*Journal of Clinical Endocrinology & Metabolism, 1983
- Papillary thyroid carcinoma: the impact of therapy in 576 patients.1977